Skip to Content
Merck
CN

I-025

Interference Mix 3 (For Qualitative Use Only)

50-1000 μg/mL each component in acetonitrile, analytical standard, Cerilliant®

Synonym(s):

Qualitative Interference Mixture

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.24
UNSPSC Code:
41116107

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

analytical standard

form

liquid

composition

Aripiprazole, 100 μg/mL , Lacosamide, 100 μg/mL , Oxcarbazepine, 100 μg/mL , (+)-Propoxyphene, 50 μg/mL , Rufinamide, 100 μg/mL , Warfarin, 1000 μg/mL

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant®

drug control

estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal), kontrollierte Droge in Deutschland

Quality Level

100

concentration

50-1000 μg/mL each component in acetonitrile

technique(s)

gas chromatography (GC): suitable, liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

multi-component solution

storage temp.

−20°C

Related Categories

General description

A multi-component solution standard of routinely monitored over-the-counter (OTC) and prescription drugs (+)-propoxyphene; aripiprazole; lacosamide; oxcarbazepine; rufinamide; and warfarin. This standard is for qualitative use only in the evaluation of interferences between the mix components and target analytes of interest in a testing laboratory′s analytical methods.

Legal Information

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.
CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 1A - STOT RE 2

target_organs

Blood

Storage Class

3 - Flammable liquids

wgk

WGK 2

flash_point_f

35.6 °F - closed cup

flash_point_c

2.0 °C - closed cup

Regulatory Information

监管及禁止进口产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service